Literature DB >> 32811605

Frequency of COVID-19 IgG Antibodies among Special Police Squad Lahore, Pakistan.

Omar Rasheed Chughtai1, Hijab Batool2, Muhammad Dilawar Khan2, Akhtar Sohail Chughtai3.   

Abstract

OBJECTIVE: To find out the sero-prevalence of COVID-19 IgG antibodies among policemen performing duties at high risk areas of Lahore, Pakistan. STUDY
DESIGN: Cross-sectional, observational study. PLACE AND DURATION OF STUDY: Chughtai Lab Lahore from 20th to 30th May 2020.
METHODOLOGY: One hundred and fifty-four young policemen (mean age 27.1 ±3.8 years) were included in the study after written consent. Squad officers who had any sign of acute respiratory infection were excluded from the study. The participants were asked to fill a questionnaire regarding nature of exposure with the infected cases, kind of personal protective equipment they are provided with and living arrangements. Three ml of blood samples were collected from the participants and immediately sent to the lab for analysis. COVID-19 IgG antibodies were analysed using chemiluminescence immunoassay method on Architect Ci8200 (Abbott). SPSS 23.0 was used for data analysis.
RESULTS: All participants were males and mean age was 27.1 ±3.8 years. Out of 154 squad members, 24 were reactive for COVID-19 IgG antibodies and performing duties at the areas of high virus exposure. None of COVID-19 IgG reactive cases exhibited symptoms and most of them performed duties at high risk areas with only masks provided as personal protective equipment. Only 10% of the participants who were exposed to confirmed cases of COVID-19 were found to have anti-COVID IgG.
CONCLUSION: COVID-19 IgG antibody reactive cases may not show any symptoms. Police force is at high risk of exposure. Serosurveys can help to find the spread of infection in the community and aid in planning healthcare strategies. Key Words: COVID-19, SARS CoV-2, Seroprevalence, Pandemic, Asymptomatic cases.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32811605     DOI: 10.29271/jcpsp.2020.07.735

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

1.  Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohort.

Authors:  Parham Sendi; Marc Thierstein; Nadja Widmer; Flora Babongo Bosombo; Annina Elisabeth Büchi; Dominik Güntensperger; Manuel Raphael Blum; Rossella Baldan; Caroline Tinguely; Brigitta Gahl; Dik Heg; Elitza S Theel; Elie Berbari; Andrea Endimiani; Peter Gowland; Christoph Niederhauser
Journal:  Immun Inflamm Dis       Date:  2022-07

2.  Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.

Authors:  Wajiha Javed; Syed Hussain Baqar Abidi; Jaffer Bin Baqar
Journal:  BMC Infect Dis       Date:  2022-05-20       Impact factor: 3.667

3.  SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?

Authors:  Mohsina Haq; Asif Rehman; Junaid Ahmad; Usman Zafar; Sufyan Ahmed; Mumtaz Ali Khan; Asif Naveed; Hala Rajab; Fawad Muhammad; Wasifa Naushad; Muhammad Aman; Hafeez Ur Rehman; Sajjad Ahmad; Saeed Anwar; Najib Ul Haq
Journal:  Infection       Date:  2021-05-25       Impact factor: 7.455

4.  A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study.

Authors:  Parham Sendi; Rossella Baldan; Marc Thierstein; Nadja Widmer; Peter Gowland; Brigitta Gahl; Annina Elisabeth Büchi; Dominik Güntensperger; Manon Wider; Manuel Raphael Blum; Caroline Tinguely; Cédric Maillat; Elitza S Theel; Elie Berbari; Ronald Dijkman; Christoph Niederhauser
Journal:  Open Forum Infect Dis       Date:  2021-10-16       Impact factor: 3.835

Review 5.  Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review.

Authors:  Chih-Cheng Lai; Jui-Hsiang Wang; Po-Ren Hsueh
Journal:  Int J Infect Dis       Date:  2020-10-09       Impact factor: 3.623

6.  Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan.

Authors:  Muhammad Imran Nisar; Nadia Ansari; Farah Khalid; Mashal Amin; Hamna Shahbaz; Aneeta Hotwani; Najeeb Rehman; Sierra Pugh; Usma Mehmood; Arjumand Rizvi; Arslan Memon; Zahoor Ahmed; Ashfaque Ahmed; Junaid Iqbal; Ali Faisal Saleem; Uzma Bashir Aamir; Daniel B Larremore; Bailey Fosdick; Fyezah Jehan
Journal:  Int J Infect Dis       Date:  2021-03-15       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.